{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:02:55Z","timestamp":1790830975926,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK47420"],"award-info":[{"award-number":["R01 DK47420"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["F31 DK126539"],"award-info":[{"award-number":["F31 DK126539"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jbc.2025.110434","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:59:05Z","timestamp":1751421545000},"page":"110434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["PTH stimulation of Rankl transcription is regulated by SIK2 and 3 and mediated by CRTC2 and 3 through action of protein phosphatases 1, 2, 4, and 5"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8088-2530","authenticated-orcid":false,"given":"Michael J.","family":"Mosca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3713-1920","authenticated-orcid":false,"given":"Nagarajan","family":"Selvamurugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jobin","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Petrosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Le Henaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola C.","family":"Partridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.110434_bib1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/BF03343614","article-title":"The burden of osteoporosis","volume":"22","author":"Kanis","year":"1999","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.jbc.2025.110434_bib2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1007\/s00198-002-1340-9","article-title":"Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis","volume":"14","author":"Seeman","year":"2003","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.jbc.2025.110434_bib3","first-page":"690","article-title":"Anabolic actions of parathyroid hormone on bone","volume":"14","author":"Dempster","year":"1993","journal-title":"Endocr. Rev"},{"key":"10.1016\/j.jbc.2025.110434_bib4","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1210\/endo.142.9.8356","article-title":"Catabolic effects of continuous human PTH (1\u201338) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation","volume":"142","author":"Ma","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.jbc.2025.110434_bib5","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra067395","article-title":"Mechanisms of anabolic therapies for osteoporosis","volume":"357","author":"Canalis","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbc.2025.110434_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11914-008-0005-9","article-title":"Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window","volume":"6","author":"Bilezikian","year":"2008","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.jbc.2025.110434_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41232-019-0111-3","article-title":"RANKL biology: bone metabolism, the immune system, and beyond","volume":"40","author":"Ono","year":"2020","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.jbc.2025.110434_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","article-title":"Osteoclast differentiation by RANKL and OPG signaling pathways","volume":"39","author":"Udagawa","year":"2021","journal-title":"J. Bone Min. Metab."},{"key":"10.1016\/j.jbc.2025.110434_bib9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.292.4.490","article-title":"Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases","volume":"292","author":"Hofbauer","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jbc.2025.110434_bib10","doi-asserted-by":"crossref","first-page":"20200","DOI":"10.1074\/jbc.RA118.004751","article-title":"Parathyroid hormone (1-34) and its analogs differentially modulate osteoblastic Rankl expression via PKA\/SIK2\/SIK3 and PP1\/PP2A-CRTC3 signaling","volume":"293","author":"Ricarte","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110434_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11154-010-9153-1","article-title":"Cellular mechanisms of bone remodeling","volume":"11","author":"Eriksen","year":"2010","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.jbc.2025.110434_bib12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.molcel.2003.08.013","article-title":"TORCs: transducers of regulated CREB activity","volume":"12","author":"Conkright","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2025.110434_bib13","doi-asserted-by":"crossref","first-page":"12147","DOI":"10.1073\/pnas.1932773100","article-title":"Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells","volume":"100","author":"Iourgenko","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110434_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cell.2004.09.015","article-title":"The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector","volume":"119","author":"Screaton","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110434_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13176","article-title":"SIKs control osteocyte responses to parathyroid hormone","volume":"7","author":"Wein","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.110434_bib16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.tem.2018.08.004","article-title":"Salt-Inducible Kinases: physiology, regulation by cAMP, and therapeutic potential","volume":"29","author":"Wein","year":"2018","journal-title":"Trends Endo. Metab."},{"key":"10.1016\/j.jbc.2025.110434_bib17","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1042\/BCJ20200502","article-title":"Nuts and bolts of the salt-inducible kinases (SIKs)","volume":"478","author":"Darling","year":"2021","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2025.110434_bib18","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1111\/j.1742-4658.2006.05291.x","article-title":"Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade","volume":"273","author":"Katoh","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.jbc.2025.110434_bib19","doi-asserted-by":"crossref","first-page":"16986","DOI":"10.1073\/pnas.1215450109","article-title":"Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages","volume":"109","author":"Clark","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110434_bib20","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.cell.2013.08.004","article-title":"The CRTC1-SIK1 pathway regulates entrainment of the circadian clock","volume":"154","author":"Jagannath","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110434_bib21","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nature03967","article-title":"The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism","volume":"437","author":"Koo","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.110434_bib22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/febs.14351","article-title":"14-3-3 proteins mediate inhibitory effects of cAMP on salt-inducible kinases (SIKs)","volume":"285","author":"Sonntag","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.jbc.2025.110434_bib23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00125-016-4141-y","article-title":"Salt-inducible kinase 2 and -3 are downregulated in adipose tissue from obese or insulin-resistant individuals: implications for insulin signalling and glucose uptake in human adipocytes","volume":"60","author":"S\u00e4ll","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.jbc.2025.110434_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146152","article-title":"Metformin improves diabetic bone health by re-balancing catabolism and nitrogen disposal","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2025.110434_bib25","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1002\/jcb.23206","article-title":"Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats","volume":"112","author":"Mai","year":"2011","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.jbc.2025.110434_bib26","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.cell.2009.10.006","article-title":"Serine\/threonine phosphatases: mechanism through structure","volume":"139","author":"Shi","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110434_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrm3072","article-title":"CREB and the CRTC co-activators: sensors for hormonal and metabolic signals","volume":"12","author":"Altarejos","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2025.110434_bib28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.isci.2018.12.012","article-title":"Mitogenic signals stimulate the CREB coactivator CRTC3 through PP2A recruitment","volume":"11","author":"Sonntag","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.jbc.2025.110434_bib29","doi-asserted-by":"crossref","first-page":"17704","DOI":"10.1073\/pnas.1012665107","article-title":"Suppressor of MEK null (SMEK)\/protein phosphatase 4 catalytic subunit (PP4C) is a key regulator of hepatic gluconeogenesis","volume":"107","author":"Yoon","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110434_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.166874","article-title":"Structural insights into the interaction between CRTCs and 14-3-3","volume":"433","author":"Chen","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jbc.2025.110434_bib31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41392-022-01038-3","article-title":"Targeting protein phosphatases for the treatment of inflammation-related diseases: from signaling to therapy","volume":"7","author":"Pan","year":"2022","journal-title":"Signal. Transduct. Targeted Ther."},{"key":"10.1016\/j.jbc.2025.110434_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/bs.apcsb.2020.06.004","article-title":"Controlling Ser\/Thr protein phosphatase PP1 activity and function through interaction with regulatory subunits","volume":"122","author":"Casamayor","year":"2020","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.jbc.2025.110434_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/bs.acr.2019.03.009","article-title":"PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer","volume":"144","author":"Fowle","year":"2019","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.jbc.2025.110434_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.emboj.7600496","article-title":"Molecular basis for TPR domain-mediated regulation of protein phosphatase 5","volume":"24","author":"Yang","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2025.110434_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12964-020-00636-4","article-title":"Calcineurin","volume":"18","author":"Creamer","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.jbc.2025.110434_bib36","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvad156","article-title":"Differential effects of PTH (1-34), PTHrP (1-36), and abaloparatide on the murine osteoblast transcriptome","volume":"8","author":"Mosca","year":"2023","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.jbc.2025.110434_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00774-020-01157-3","article-title":"Mechanisms of RANKL delivery to the osteoclast precursor cell surface","volume":"39","author":"Honma","year":"2021","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.jbc.2025.110434_bib38","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.molmed.2013.02.001","article-title":"cAMP responsive element modulator: a critical regulator of cytokine production","volume":"19","author":"Rauen","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jbc.2025.110434_bib39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/jcb.240500411","article-title":"Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes","volume":"50","author":"Shalhoub","year":"1992","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.jbc.2025.110434_bib40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110434_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/03008208909023869","article-title":"The onset and progression of osteoblast differentiation is functionally related to cellular proliferation","volume":"20","author":"Stein","year":"1989","journal-title":"Connect. Tissues Res."},{"key":"10.1016\/j.jbc.2025.110434_bib42","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/jcp.1041430304","article-title":"Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix","volume":"143","author":"Owen","year":"1990","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.jbc.2025.110434_bib43","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jcb.240550205","article-title":"Transcriptionally active nuclei isolated from intact bone reflect modified levels of gene expression in skeletal development and pathology","volume":"55","author":"Shalhoub","year":"1994","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.jbc.2025.110434_bib44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jcp.1041580114","article-title":"Abnormalities of phosphoprotein gene expression in three osteopetrotic rat mutations: elevated mRNA transcripts, protein synthesis, and accumulation in bone of mutant animals","volume":"158","author":"Shalhoub","year":"1994","journal-title":"J. Cell Physiol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825022847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825022847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T23:38:44Z","timestamp":1756424324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825022847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0021925825022847"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110434","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PTH stimulation of Rankl transcription is regulated by SIK2 and 3 and mediated by CRTC2 and 3 through action of protein phosphatases 1, 2, 4, and 5","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"110434"}}